Abstract | BACKGROUND: OBJECTIVE: To investigate the clinical and genetic variables that can be associated with the cognitive decline in patients with MS. METHODS: Five-hundred and three patients with clinically definite MS underwent a battery of neuropsychological tests and, according to the number of failed tests, were divided into cognitively normal and impaired. All patients were genotyped for APOE gene polymorphisms. RESULTS: Fifty-six percent of MS patients showed, to different extents, cognitive impairment. Cognitive decline was predominant in men and was associated with disease duration, Kurtzke Expanded Disability Status Scale (EDSS) score, a low level of education, and, interestingly, the epsilon4 allele of the APOE gene. By contrast, cognitive impairment in women was independent of any investigated variable. CONCLUSION: The findings demonstrate that clinical and genetic factors play a role in men affected by MS developing cognitive impairment.
|
Authors | Giovanni Savettieri, Demetrio Messina, Virginia Andreoli, Simona Bonavita, Carlo Caltagirone, Rita Cittadella, Deborah Farina, Maria Carolina Fazio, Paolo Girlanda, Francesco Le Pira, Maria Liguori, Alessandra Lugaresi, Ugo Nocentini, Arturo Reggio, Giuseppe Salemi, Gioacchino Tedeschi, Maria Trojano, Paola Valentino, Aldo Quattrone |
Journal | Journal of neurology
(J Neurol)
Vol. 251
Issue 10
Pg. 1208-14
(Oct 2004)
ISSN: 0340-5354 [Print] Germany |
PMID | 15503099
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Apolipoproteins E
- RNA, Messenger
|
Topics |
- Adult
- Analysis of Variance
- Apolipoproteins E
(genetics)
- Chi-Square Distribution
- Cognition Disorders
(etiology, genetics)
- Female
- Genetic Variation
- Humans
- Male
- Middle Aged
- Multiple Sclerosis
(complications, genetics)
- Neuropsychological Tests
(statistics & numerical data)
- Odds Ratio
- RNA, Messenger
(metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
(methods)
- Sex Characteristics
|